216 related articles for article (PubMed ID: 36254680)
1. Probing the origin of prion protein misfolding via reconstruction of ancestral proteins.
Cortez LM; Morrison AJ; Garen CR; Patterson S; Uyesugi T; Petrosyan R; Sekar RV; Harms MJ; Woodside MT; Sim VL
Protein Sci; 2022 Dec; 31(12):e4477. PubMed ID: 36254680
[TBL] [Abstract][Full Text] [Related]
2.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
3. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
[TBL] [Abstract][Full Text] [Related]
4. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification.
Camacho MV; Telling G; Kong Q; Gambetti P; Notari S
Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the PrPc Amino-Terminal Domain in Prion Species Barriers.
Davenport KA; Henderson DM; Mathiason CK; Hoover EA
J Virol; 2016 Dec; 90(23):10752-10761. PubMed ID: 27654299
[TBL] [Abstract][Full Text] [Related]
6. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.
Barron RM; King D; Jeffrey M; McGovern G; Agarwal S; Gill AC; Piccardo P
Acta Neuropathol; 2016 Oct; 132(4):611-24. PubMed ID: 27376534
[TBL] [Abstract][Full Text] [Related]
7. Porcine prion protein amyloid.
Hammarström P; Nyström S
Prion; 2015; 9(4):266-77. PubMed ID: 26218890
[TBL] [Abstract][Full Text] [Related]
8. Molecular dynamics studies on the buffalo prion protein.
Zhang J; Wang F; Chatterjee S
J Biomol Struct Dyn; 2016; 34(4):762-77. PubMed ID: 26043781
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of prion protein amyloid seeding from transmission of a spongiform encephalopathy.
Piccardo P; King D; Telling G; Manson JC; Barron RM
J Virol; 2013 Nov; 87(22):12349-56. PubMed ID: 24027305
[TBL] [Abstract][Full Text] [Related]
10.
Meyerett-Reid C; Wyckoff AC; Spraker T; Pulford B; Bender H; Zabel MD
mSphere; 2017; 2(1):. PubMed ID: 28144628
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Mammalian Prions: The "Correctly" Misfolded Prion Protein Conformers.
Ma J; Zhang J; Yan R
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146746
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
13. Heterozygosity for cervid S138N polymorphism results in subclinical CWD in gene-targeted mice and progressive inhibition of prion conversion.
Arifin MI; Kaczmarczyk L; Zeng D; Hannaoui S; Lee C; Chang SC; Mitchell G; McKenzie D; Beekes M; Jackson W; Gilch S
Proc Natl Acad Sci U S A; 2023 Apr; 120(15):e2221060120. PubMed ID: 37014866
[TBL] [Abstract][Full Text] [Related]
14. Species-barrier phenomenon in prion transmissibility from a viewpoint of protein science.
Hagiwara K; Hara H; Hanada K
J Biochem; 2013 Feb; 153(2):139-45. PubMed ID: 23284000
[TBL] [Abstract][Full Text] [Related]
15. Soluble polymorphic bank vole prion proteins induced by co-expression of quiescin sulfhydryl oxidase in E. coli and their aggregation behaviors.
Abskharon R; Dang J; Elfarash A; Wang Z; Shen P; Zou LS; Hassan S; Wang F; Fujioka H; Steyaert J; Mulaj M; Surewicz WK; Castilla J; Wohlkonig A; Zou WQ
Microb Cell Fact; 2017 Oct; 16(1):170. PubMed ID: 28978309
[TBL] [Abstract][Full Text] [Related]
16. Location of the cross-β structure in prion fibrils: A search by seeding and electron spin resonance spectroscopy.
Chu BK; Tsai RF; Hung CL; Kuo YH; Chen EH; Chiang YW; Chan SI; Chen RP
Protein Sci; 2022 Jun; 31(6):e4326. PubMed ID: 35634767
[TBL] [Abstract][Full Text] [Related]
17. Protein misfolding cyclic amplification (PMCA): Current status and future directions.
Saá P; Cervenakova L
Virus Res; 2015 Sep; 207():47-61. PubMed ID: 25445341
[TBL] [Abstract][Full Text] [Related]
18. Molecular interactions between prions as seeds and recombinant prion proteins as substrates resemble the biological interspecies barrier in vitro.
Panza G; Luers L; Stöhr J; Nagel-Steger L; Weiss J; Riesner D; Willbold D; Birkmann E
PLoS One; 2010 Dec; 5(12):e14283. PubMed ID: 21151607
[TBL] [Abstract][Full Text] [Related]
19. Generic amyloidogenicity of mammalian prion proteins from species susceptible and resistant to prions.
Nyström S; Hammarström P
Sci Rep; 2015 May; 5():10101. PubMed ID: 25960067
[TBL] [Abstract][Full Text] [Related]
20. Prion disease: a deadly disease for protein misfolding.
Chakraborty C; Nandi S; Jana S
Curr Pharm Biotechnol; 2005 Apr; 6(2):167-77. PubMed ID: 15853695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]